Vera Therapeutics Inc. (VERA) NASDAQ

$43.83 2.25 (5.41%)

Market Cap: $2.41B

As of 03/27/24 04:00 PM EDT. Market closed.

(VERA)

Vera Therapeutics Inc. (VERA)
NASDAQ

$43.83
2.25 (5.41%)

Market Cap: $2.41B

As of 03/27/24 04:00 PM EDT. Market closed.

Add to Portfolio

trucode gene repair is advancing its novel triplex gene editing platform to potentially cure devastating genetic diseases, with initial focus on sickle cell disease and cystic fibrosis. the elegance of triplex gene editing lies in its ability to harness natural, high-fidelity dna repair mechanisms, and its independence from the requirement for exogenous nucleases and viral ... read more

trucode gene repair is advancing its novel triplex gene editing platform to potentially cure devastating genetic diseases, with initial focus on sickle cell disease and cystic fibrosis. the elegance of triplex gene editing lies in its ability to harness natural, high-fidelity dna repair mechanisms, and its independence from the requirement for exogenous nucleases and viral vectors. read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Full Time Employees
46
URL
Address
.
PRICE CHART FOR VERA THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$41.58
Days Range
$41.50 - $44
52 week range
$5.95 - $50.78
Volume
0
Avg. Volume (30 days)
867,814
Market Cap
$2.41B
Dividend Yield
-
P/E
-
Shares Outstanding
54,916,816
Open
-
Previous Close
$41.58
Days Range
$41.50 - $44
52 week range
$5.95 - $50.78
Volume
0
Avg. Volume (30 days)
867,814
Market Cap
$2.41B
Dividend Yield
-
P/E
-
Shares Outstanding
54,916,816
FINANCIAL STATEMENTS FOR VERA THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR VERA THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Katabi MahaDirectorMar 22, 2024 Sale$40.51413,45016,748,8593,133,987Mar 25, 2024, 09:46 PM
Katabi MahaDirectorMar 21, 2024 Sale$44.2081,0093,580,7233,595,690Mar 25, 2024, 09:46 PM
Katabi MahaDirectorMar 25, 2024 Sale$40.50340,00013,770,0002,793,987Mar 25, 2024, 09:46 PM
Katabi MahaDirectorJan 30, 2024 Buy$31.00161,2904,999,9903,628,446Feb 01, 2024, 05:58 PM
COMMODORE CAPITAL LP10% OwnerJan 10, 2024 Sale$18.001,050,00018,900,0004,400,000Jan 12, 2024, 09:55 PM
Lin CeliaChief Medical OfficerAug 21, 2023 Sale$16.651,49024,81611,010Aug 23, 2023, 05:59 PM
Curley JoanneChief Development OfficerAug 21, 2023 Sale$16.661,49024,81726,962Aug 23, 2023, 05:57 PM
Fordyce MarshallPresident and CEOAug 21, 2023 Sale$16.665,21086,779243,361Aug 23, 2023, 05:56 PM
Young Joseph RSVP, Finance, Chief Acct OffcrJul 05, 2023 Option Exercise$3.9410,00039,39632,679Jul 06, 2023, 04:05 PM
Grant SeanChief Financial OfficerJun 23, 2023 Buy$16.605,00083,0005,992Jun 23, 2023, 04:05 PM
COMMODORE CAPITAL LP10% OwnerJun 20, 2023 Buy$15.17448,2176,799,0045,450,000Jun 22, 2023, 04:10 PM
SEIDENBERG BETH CDirectorMar 30, 2023 Buy$7.242,30016,6511,949,295Apr 03, 2023, 04:05 PM
SEIDENBERG BETH CDirectorMar 28, 2023 Buy$7.2423,908173,1921,946,995Mar 30, 2023, 04:07 PM
SEIDENBERG BETH CDirectorMar 24, 2023 Buy$7.241,83313,2721,921,454Mar 28, 2023, 04:05 PM
SEIDENBERG BETH CDirectorMar 27, 2023 Buy$7.241,63311,8301,923,087Mar 28, 2023, 04:05 PM
SEIDENBERG BETH CDirectorMar 20, 2023 Buy$7.2115,252110,0331,919,621Mar 21, 2023, 04:40 PM
SEIDENBERG BETH CDirectorMar 17, 2023 Buy$7.1274,045526,8821,904,369Mar 21, 2023, 04:40 PM
SEIDENBERG BETH CDirectorMar 16, 2023 Buy$7.0960,097426,2681,830,324Mar 17, 2023, 04:10 PM
SEIDENBERG BETH CDirectorMar 15, 2023 Buy$7.1232,844234,0101,770,227Mar 17, 2023, 04:10 PM
SEIDENBERG BETH CDirectorMar 10, 2023 Buy$7.1648,003343,4851,737,383Mar 14, 2023, 04:05 PM
SEIDENBERG BETH CDirectorMar 03, 2023 Buy$7.241,0007,2451,689,380Mar 07, 2023, 04:07 PM
SEIDENBERG BETH CDirectorFeb 23, 2023 Buy$7.242001,4471,664,902Feb 27, 2023, 04:07 PM
Young Joseph RSVP, Finance, Chief Acct OffcrFeb 06, 2023 Buy$7.005,71439,99822,679Feb 17, 2023, 04:19 PM
SEIDENBERG BETH CDirectorFeb 13, 2023 Buy$7.2010,07272,4901,664,702Feb 15, 2023, 06:32 PM
SEIDENBERG BETH CDirectorFeb 09, 2023 Buy$7.254002,9001,654,630Feb 13, 2023, 04:04 PM
SEIDENBERG BETH CDirectorFeb 06, 2023 Buy$7.03131,602925,1621,520,917Feb 09, 2023, 04:36 PM
SEIDENBERG BETH CDirectorFeb 03, 2023 Buy$7.2446,163334,2201,389,315Feb 09, 2023, 04:36 PM
SEIDENBERG BETH CDirectorFeb 08, 2023 Buy$7.2245,357327,4781,654,230Feb 09, 2023, 04:36 PM
SEIDENBERG BETH CDirectorFeb 07, 2023 Buy$7.0887,956622,7281,608,873Feb 09, 2023, 04:36 PM
Longitude Capital Partners IV, LLC10% OwnerFeb 06, 2023 Buy$7.001,714,28511,999,9951,714,285Feb 08, 2023, 07:40 PM
ENRIGHT PATRICK GDirectorFeb 06, 2023 Buy$7.001,714,28511,999,9951,714,285Feb 08, 2023, 07:32 PM
Sofinnova Venture Partners X, L.P.10% OwnerFeb 06, 2023 Buy$7.00285,7141,999,9983,467,156Feb 08, 2023, 06:29 PM
Young Joseph RSVP, Finance, Chief Acct OffcrFeb 06, 2022 Buy$7.005,71439,99822,679Feb 08, 2023, 04:05 PM
Grant SeanChief Financial OfficerFeb 06, 2022 Buy$7.0014,28599,99549,933Feb 08, 2023, 04:04 PM
Curley JoanneChief Development OfficerDec 16, 2022 Option Exercise$2.902,2126,40828,250Dec 19, 2022, 05:01 PM
Curley JoanneChief Development OfficerDec 16, 2022 Sale$19.492,21243,11626,821Dec 19, 2022, 05:01 PM
Curley JoanneChief Development OfficerDec 13, 2022 Option Exercise$10.6112,811135,93338,554Dec 14, 2022, 04:08 PM
Curley JoanneChief Development OfficerDec 12, 2022 Option Exercise$11.006,90075,90033,721Dec 14, 2022, 04:08 PM
Curley JoanneChief Development OfficerDec 13, 2022 Sale$18.2712,811234,04926,821Dec 14, 2022, 04:08 PM
Curley JoanneChief Development OfficerDec 12, 2022 Sale$18.256,900125,92426,821Dec 14, 2022, 04:08 PM
Curley JoanneChief Development OfficerDec 07, 2022 Sale$16.474948,13626,821Dec 08, 2022, 04:06 PM
Curley JoanneChief Development OfficerNov 17, 2022 Option Exercise$4.043,28913,27529,526Nov 21, 2022, 04:08 PM
Curley JoanneChief Development OfficerNov 17, 2022 Sale$15.853,28952,12827,315Nov 21, 2022, 04:08 PM
Fordyce MarshallPresident and CEONov 16, 2022 Option Exercise$2.8565,153185,750246,303Nov 17, 2022, 04:06 PM
Curley JoanneChief Development OfficerNov 09, 2022 Sale$16.544948,17127,315Nov 10, 2022, 04:04 PM
Curley JoanneChief Development OfficerOct 18, 2022 Option Exercise$8.338,59071,57833,107Oct 20, 2022, 04:37 PM
Curley JoanneChief Development OfficerOct 18, 2022 Sale$19.418,590166,73527,809Oct 20, 2022, 04:37 PM
Curley JoanneChief Development OfficerOct 05, 2022 Sale$21.6498821,38027,809Oct 06, 2022, 04:04 PM
Fordyce MarshallPresident and CEOOct 04, 2022 Option Exercise$2.9018,22352,788191,568Oct 05, 2022, 04:05 PM
Fordyce MarshallPresident and CEOOct 03, 2022 Option Exercise$2.9013,77739,909192,519Oct 05, 2022, 04:05 PM
Fordyce MarshallPresident and CEOOct 04, 2022 Sale$21.1918,223386,065181,150Oct 05, 2022, 04:05 PM
Fordyce MarshallPresident and CEOOct 03, 2022 Sale$20.5213,777282,708181,150Oct 05, 2022, 04:05 PM
Curley JoanneChief Development OfficerSep 21, 2022 Option Exercise$11.001,17412,91429,707Sep 22, 2022, 04:06 PM
Curley JoanneChief Development OfficerSep 20, 2022 Option Exercise$9.5615,666149,81938,909Sep 22, 2022, 04:06 PM
Curley JoanneChief Development OfficerSep 21, 2022 Sale$21.401,17425,12428,797Sep 22, 2022, 04:06 PM
Curley JoanneChief Development OfficerSep 20, 2022 Sale$20.6715,666323,82028,797Sep 22, 2022, 04:06 PM
Fordyce MarshallPresident and CEOSep 13, 2022 Option Exercise$2.9022,36364,781193,350Sep 14, 2022, 04:12 PM
Fordyce MarshallPresident and CEOSep 13, 2022 Sale$21.1622,363473,236181,150Sep 14, 2022, 04:12 PM
Fordyce MarshallPresident and CEOSep 12, 2022 Option Exercise$2.9016,13646,743193,971Sep 13, 2022, 04:04 PM
Fordyce MarshallPresident and CEOSep 09, 2022 Option Exercise$2.9012,88637,328194,036Sep 13, 2022, 04:04 PM
Fordyce MarshallPresident and CEOSep 09, 2022 Sale$20.1612,886259,771181,150Sep 13, 2022, 04:04 PM
Fordyce MarshallPresident and CEOSep 12, 2022 Sale$20.6416,136333,041181,150Sep 13, 2022, 04:04 PM
Fordyce MarshallPresident and CEOSep 07, 2022 Option Exercise$2.906,78519,655187,935Sep 09, 2022, 04:23 PM
Fordyce MarshallPresident and CEOSep 08, 2022 Option Exercise$2.9015,10643,759196,256Sep 09, 2022, 04:23 PM
Fordyce MarshallPresident and CEOSep 08, 2022 Sale$20.5215,106309,975181,150Sep 09, 2022, 04:23 PM
Fordyce MarshallPresident and CEOSep 07, 2022 Sale$20.036,785135,904181,150Sep 09, 2022, 04:23 PM
Curley JoanneChief Development OfficerSep 07, 2022 Sale$18.6398818,40628,797Sep 08, 2022, 04:41 PM
Fordyce MarshallPresident and CEOSep 02, 2022 Option Exercise$2.9017,09649,524190,900Sep 06, 2022, 04:29 PM
Fordyce MarshallPresident and CEOSep 01, 2022 Option Exercise$2.9017,10049,535198,250Sep 06, 2022, 04:29 PM
Fordyce MarshallPresident and CEOSep 02, 2022 Sale$20.9717,096358,453181,150Sep 06, 2022, 04:29 PM
Fordyce MarshallPresident and CEOSep 01, 2022 Sale$21.2217,100362,783181,150Sep 06, 2022, 04:29 PM
Curley JoanneChief Development OfficerAug 22, 2022 Option Exercise$11.001,63017,93030,815Aug 23, 2022, 04:15 PM
Curley JoanneChief Development OfficerAug 19, 2022 Option Exercise$7.746,90953,50032,551Aug 23, 2022, 04:15 PM
Curley JoanneChief Development OfficerAug 19, 2022 Sale$19.206,909132,62529,785Aug 23, 2022, 04:15 PM
Curley JoanneChief Development OfficerAug 22, 2022 Sale$18.871,63030,76429,785Aug 23, 2022, 04:15 PM
Carlyle Group Inc.10% OwnerAug 17, 2022 Option Exercise$11.009,925109,1752,970,156Aug 19, 2022, 04:39 PM
Carlyle Group Inc.10% OwnerAug 17, 2022 Sale$20.259,925201,0262,966,875Aug 19, 2022, 04:39 PM
Fordyce MarshallPresident and CEOAug 12, 2022 Option Exercise$2.9020,52859,466157,928Aug 15, 2022, 04:11 PM
Fordyce MarshallPresident and CEOAug 12, 2022 Sale$20.1620,528413,799137,400Aug 15, 2022, 04:11 PM
Curley JoanneChief Development OfficerAug 03, 2022 Sale$16.8198816,60817,285Aug 04, 2022, 04:07 PM
Curley JoanneChief Development OfficerJul 19, 2022 Option Exercise$4.5311,44451,88724,319Jul 20, 2022, 04:08 PM
Curley JoanneChief Development OfficerJul 19, 2022 Sale$16.0111,444183,27118,273Jul 20, 2022, 04:08 PM
Curley JoanneChief Development OfficerJul 14, 2022 Option Exercise$2.906,35418,40627,377Jul 15, 2022, 04:41 PM
Curley JoanneChief Development OfficerJul 14, 2022 Sale$15.149,104137,86421,023Jul 15, 2022, 04:41 PM
Curley JoanneChief Development OfficerJul 07, 2022 Option Exercise$4.637,00132,40127,202Jul 11, 2022, 04:04 PM
Curley JoanneChief Development OfficerJul 07, 2022 Sale$15.059,666145,45323,688Jul 11, 2022, 04:04 PM
Curley JoanneChief Development OfficerJun 22, 2022 Option Exercise$6.371,2397,89625,233Jun 23, 2022, 06:49 PM
Curley JoanneChief Development OfficerJun 22, 2022 Sale$15.011,54523,19823,994Jun 23, 2022, 06:49 PM
Curley JoanneChief Development OfficerJun 17, 2022 Option Exercise$3.904,68718,25628,535Jun 21, 2022, 08:16 PM
Curley JoanneChief Development OfficerJun 17, 2022 Sale$15.045,88788,56525,194Jun 21, 2022, 08:16 PM
Grant SeanChief Financial OfficerJun 15, 2022 Buy$13.6085711,656857Jun 16, 2022, 04:06 PM
Grant SeanChief Financial OfficerJun 15, 2022 Buy$13.603354,556335Jun 16, 2022, 04:06 PM
Grant SeanChief Financial OfficerJun 15, 2022 Buy$13.602,81638,3002,816Jun 16, 2022, 04:06 PM
Grant SeanChief Financial OfficerJun 15, 2022 Buy$13.6099213,492992Jun 16, 2022, 04:06 PM
Curley JoanneChief Development OfficerMay 31, 2022 Option Exercise$6.374002,54925,594Jun 02, 2022, 04:06 PM
Curley JoanneChief Development OfficerMay 31, 2022 Sale$15.224006,08625,194Jun 02, 2022, 04:06 PM
Longitude Capital Partners IV, LLC10% OwnerFeb 10, 2022 Buy$15.00333,3334,999,9953,429,927Apr 05, 2022, 07:24 AM
ENRIGHT PATRICK GDirectorFeb 10, 2022 Buy$15.00333,3334,999,9953,429,927Apr 05, 2022, 07:22 AM
Sofinnova Venture Partners X, L.P.10% OwnerFeb 10, 2022 Buy$15.00266,6663,999,9903,181,442Feb 14, 2022, 06:17 PM
Sofinnova Venture Partners X, L.P.10% OwnerMay 18, 2021 Buy$11.00727,2727,999,9922,914,776May 18, 2021, 08:23 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Katabi MahaDirector03/22/202416,748,859
Katabi MahaDirector03/21/20243,580,723
Katabi MahaDirector03/25/202413,770,000
Katabi MahaDirector01/30/20244,999,990
COMMODORE CAPITAL LP10% Owner01/10/202418,900,000
Lin CeliaChief Medical Officer08/21/202324,816
Curley JoanneChief Development Officer08/21/202324,817
Fordyce MarshallPresident and CEO08/21/202386,779
Young Joseph RSVP, Finance, Chief Acct Offcr07/05/202339,396
Grant SeanChief Financial Officer06/23/202383,000
COMMODORE CAPITAL LP10% Owner06/20/20236,799,004
SEIDENBERG BETH CDirector03/30/202316,651
SEIDENBERG BETH CDirector03/28/2023173,192
SEIDENBERG BETH CDirector03/24/202313,272
SEIDENBERG BETH CDirector03/27/202311,830
SEIDENBERG BETH CDirector03/20/2023110,033
SEIDENBERG BETH CDirector03/17/2023526,882
SEIDENBERG BETH CDirector03/16/2023426,268
SEIDENBERG BETH CDirector03/15/2023234,010
SEIDENBERG BETH CDirector03/10/2023343,485
SEIDENBERG BETH CDirector03/03/20237,245
SEIDENBERG BETH CDirector02/23/20231,447
Young Joseph RSVP, Finance, Chief Acct Offcr02/06/202339,998
SEIDENBERG BETH CDirector02/13/202372,490
SEIDENBERG BETH CDirector02/09/20232,900
SEIDENBERG BETH CDirector02/06/2023925,162
SEIDENBERG BETH CDirector02/03/2023334,220
SEIDENBERG BETH CDirector02/08/2023327,478
SEIDENBERG BETH CDirector02/07/2023622,728
Longitude Capital Partners IV, LLC10% Owner02/06/202311,999,995
ENRIGHT PATRICK GDirector02/06/202311,999,995
Sofinnova Venture Partners X, L.P.10% Owner02/06/20231,999,998
Young Joseph RSVP, Finance, Chief Acct Offcr02/06/202239,998
Grant SeanChief Financial Officer02/06/202299,995
Curley JoanneChief Development Officer12/16/20226,408
Curley JoanneChief Development Officer12/16/202243,116
Curley JoanneChief Development Officer12/13/2022135,933
Curley JoanneChief Development Officer12/12/202275,900
Curley JoanneChief Development Officer12/13/2022234,049
Curley JoanneChief Development Officer12/12/2022125,924
Curley JoanneChief Development Officer12/07/20228,136
Curley JoanneChief Development Officer11/17/202213,275
Curley JoanneChief Development Officer11/17/202252,128
Fordyce MarshallPresident and CEO11/16/2022185,750
Curley JoanneChief Development Officer11/09/20228,171
Curley JoanneChief Development Officer10/18/202271,578
Curley JoanneChief Development Officer10/18/2022166,735
Curley JoanneChief Development Officer10/05/202221,380
Fordyce MarshallPresident and CEO10/04/202252,788
Fordyce MarshallPresident and CEO10/03/202239,909
Fordyce MarshallPresident and CEO10/04/2022386,065
Fordyce MarshallPresident and CEO10/03/2022282,708
Curley JoanneChief Development Officer09/21/202212,914
Curley JoanneChief Development Officer09/20/2022149,819
Curley JoanneChief Development Officer09/21/202225,124
Curley JoanneChief Development Officer09/20/2022323,820
Fordyce MarshallPresident and CEO09/13/202264,781
Fordyce MarshallPresident and CEO09/13/2022473,236
Fordyce MarshallPresident and CEO09/12/202246,743
Fordyce MarshallPresident and CEO09/09/202237,328
Fordyce MarshallPresident and CEO09/09/2022259,771
Fordyce MarshallPresident and CEO09/12/2022333,041
Fordyce MarshallPresident and CEO09/07/202219,655
Fordyce MarshallPresident and CEO09/08/202243,759
Fordyce MarshallPresident and CEO09/08/2022309,975
Fordyce MarshallPresident and CEO09/07/2022135,904
Curley JoanneChief Development Officer09/07/202218,406
Fordyce MarshallPresident and CEO09/02/202249,524
Fordyce MarshallPresident and CEO09/01/202249,535
Fordyce MarshallPresident and CEO09/02/2022358,453
Fordyce MarshallPresident and CEO09/01/2022362,783
Curley JoanneChief Development Officer08/22/202217,930
Curley JoanneChief Development Officer08/19/202253,500
Curley JoanneChief Development Officer08/19/2022132,625
Curley JoanneChief Development Officer08/22/202230,764
Carlyle Group Inc.10% Owner08/17/2022109,175
Carlyle Group Inc.10% Owner08/17/2022201,026
Fordyce MarshallPresident and CEO08/12/202259,466
Fordyce MarshallPresident and CEO08/12/2022413,799
Curley JoanneChief Development Officer08/03/202216,608
Curley JoanneChief Development Officer07/19/202251,887
Curley JoanneChief Development Officer07/19/2022183,271
Curley JoanneChief Development Officer07/14/202218,406
Curley JoanneChief Development Officer07/14/2022137,864
Curley JoanneChief Development Officer07/07/202232,401
Curley JoanneChief Development Officer07/07/2022145,453
Curley JoanneChief Development Officer06/22/20227,896
Curley JoanneChief Development Officer06/22/202223,198
Curley JoanneChief Development Officer06/17/202218,256
Curley JoanneChief Development Officer06/17/202288,565
Grant SeanChief Financial Officer06/15/202211,656
Grant SeanChief Financial Officer06/15/20224,556
Grant SeanChief Financial Officer06/15/202238,300
Grant SeanChief Financial Officer06/15/202213,492
Curley JoanneChief Development Officer05/31/20222,549
Curley JoanneChief Development Officer05/31/20226,086
Longitude Capital Partners IV, LLC10% Owner02/10/20224,999,995
ENRIGHT PATRICK GDirector02/10/20224,999,995
Sofinnova Venture Partners X, L.P.10% Owner02/10/20223,999,990
Sofinnova Venture Partners X, L.P.10% Owner05/18/20217,999,992
Load More Insider Transactions
FUNDS WITH A POSITION IN VERA THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.2,754,8940.00108%16.81%Other
ORBIMED ADVISORS LLC1,518,1150.47%No changeOther
GEODE CAPITAL MANAGEMENT, LLC782,7160.00126%5.98%Other
D. E. SHAW & CO., INC.210,0390.00282%32.78%Other
PLATINUM INVESTMENT MANAGEMENT LTD200,3020.13%No changeGrowth At A Reasonable Price, Value
UBS OCONNOR LLC106,9720.12%-39.9%Value
RENAISSANCE TECHNOLOGIES LLC87,2000.00204%ExitedOther
DRIEHAUS CAPITAL MANAGEMENT LLC68,3060.01%No changeGrowth
ALPS ADVISORS INC30,2200.00365%-7.61%Other
BALYASNY ASSET MANAGEMENT L.P.10,4300.0003%NewEvent Driven
CHANGE IN SHARES OUTSTANDING FOR VERA THERAPEUTICS INC
STOCK BUYBACKS FOR VERA THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2023
06/30/2023
0.21%
1Q
09/30/2023
03/31/2023
17.78%
2Q
09/30/2023
06/30/2022
63.83%
5Q
09/30/2023
03/31/2022
83.11%
6Q
Load More

Period of Report: 09/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
0.21%
1Q
03/31/2023
17.78%
2Q
06/30/2022
63.83%
5Q
03/31/2022
83.11%
6Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR VERA THERAPEUTICS INC
LOADING...